Germany, holding up better than its eurozone partners in the current debt crisis, is battling the increasingly widespread phenomenon of “burnout” which it says is costing its economy billions of euros (dollars) each year.
Orexigen, FDA agree on trial design for obesity drug
February 6th, 2012 FAKE NEWS for the Zionist agenda